Cargando…
Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients
BACKGROUND: In Head and neck cancer (HNC) angiogenesis is essential for tumor progression and metastasis. Small extracellular vesicles (sEVs) from HNC cell lines alter endothelial cell (EC) functions towards a pro-angiogenic phenotype. However, the role of plasma sEVs retrieved from HNC patients in...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207688/ https://www.ncbi.nlm.nih.gov/pubmed/37226100 http://dx.doi.org/10.1186/s10020-023-00659-w |
_version_ | 1785046512599826432 |
---|---|
author | Tengler, Luisa Schütz, Julia Tiedtke, Moritz Jablonska, Jadwiga Theodoraki, Marie-Nicole Nitschke, Katja Weiß, Christel Seiz, Elena Affolter, Annette Jungbauer, Frederic Lammert, Anne Rotter, Nicole Ludwig, Sonja |
author_facet | Tengler, Luisa Schütz, Julia Tiedtke, Moritz Jablonska, Jadwiga Theodoraki, Marie-Nicole Nitschke, Katja Weiß, Christel Seiz, Elena Affolter, Annette Jungbauer, Frederic Lammert, Anne Rotter, Nicole Ludwig, Sonja |
author_sort | Tengler, Luisa |
collection | PubMed |
description | BACKGROUND: In Head and neck cancer (HNC) angiogenesis is essential for tumor progression and metastasis. Small extracellular vesicles (sEVs) from HNC cell lines alter endothelial cell (EC) functions towards a pro-angiogenic phenotype. However, the role of plasma sEVs retrieved from HNC patients in this process is not clear so far. METHODS: Plasma sEVs were isolated on size exclusion chromatography columns from 32 HNC patients (early-stage UICC I/II: 8, advanced-stage UICC III/IV: 24), 12 patients with no evident disease after therapy (NED) and 16 healthy donors (HD). Briefly, sEVs were characterized by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), BCA protein assays and Western blots. Levels of angiogenesis-associated proteins were determined using antibody arrays. The interaction of fluorescently-labeled sEVs with human umbilical vein ECs was visualized by confocal microscopy. The functional effect of sEVs on tubulogenesis, migration, proliferation and apoptosis of ECs was assessed. RESULTS: The internalization of sEVs by ECs was visualized using confocal microscopy. Based on antibody arrays, all plasma sEVs were enriched in anti-angiogenic proteins. HNC sEVs contained more pro-angiogenic MMP-9 and anti-angiogenic proteins (Serpin F1) than HD sEVs. Interestingly, a strong inhibition of EC function was observed for sEVs from early-stage HNC, NED and HD. In contrast, sEVs from advanced-stage HNC showed a significantly increased tubulogenesis, migration and proliferation and induced less apoptosis in ECs than sEVs from HD. CONCLUSIONS: In general, plasma sEVs carry a predominantly anti-angiogenic protein cargo and suppress the angiogenic properties of ECs, while sEVs from (advanced-stage) HNC patients induce angiogenesis compared to HD sEVs. Thus, tumor-derived sEVs within the plasma of HNC patients might shift the angiogenic switch towards angiogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00659-w. |
format | Online Article Text |
id | pubmed-10207688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102076882023-05-25 Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients Tengler, Luisa Schütz, Julia Tiedtke, Moritz Jablonska, Jadwiga Theodoraki, Marie-Nicole Nitschke, Katja Weiß, Christel Seiz, Elena Affolter, Annette Jungbauer, Frederic Lammert, Anne Rotter, Nicole Ludwig, Sonja Mol Med Research Article BACKGROUND: In Head and neck cancer (HNC) angiogenesis is essential for tumor progression and metastasis. Small extracellular vesicles (sEVs) from HNC cell lines alter endothelial cell (EC) functions towards a pro-angiogenic phenotype. However, the role of plasma sEVs retrieved from HNC patients in this process is not clear so far. METHODS: Plasma sEVs were isolated on size exclusion chromatography columns from 32 HNC patients (early-stage UICC I/II: 8, advanced-stage UICC III/IV: 24), 12 patients with no evident disease after therapy (NED) and 16 healthy donors (HD). Briefly, sEVs were characterized by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), BCA protein assays and Western blots. Levels of angiogenesis-associated proteins were determined using antibody arrays. The interaction of fluorescently-labeled sEVs with human umbilical vein ECs was visualized by confocal microscopy. The functional effect of sEVs on tubulogenesis, migration, proliferation and apoptosis of ECs was assessed. RESULTS: The internalization of sEVs by ECs was visualized using confocal microscopy. Based on antibody arrays, all plasma sEVs were enriched in anti-angiogenic proteins. HNC sEVs contained more pro-angiogenic MMP-9 and anti-angiogenic proteins (Serpin F1) than HD sEVs. Interestingly, a strong inhibition of EC function was observed for sEVs from early-stage HNC, NED and HD. In contrast, sEVs from advanced-stage HNC showed a significantly increased tubulogenesis, migration and proliferation and induced less apoptosis in ECs than sEVs from HD. CONCLUSIONS: In general, plasma sEVs carry a predominantly anti-angiogenic protein cargo and suppress the angiogenic properties of ECs, while sEVs from (advanced-stage) HNC patients induce angiogenesis compared to HD sEVs. Thus, tumor-derived sEVs within the plasma of HNC patients might shift the angiogenic switch towards angiogenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-023-00659-w. BioMed Central 2023-05-24 /pmc/articles/PMC10207688/ /pubmed/37226100 http://dx.doi.org/10.1186/s10020-023-00659-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Tengler, Luisa Schütz, Julia Tiedtke, Moritz Jablonska, Jadwiga Theodoraki, Marie-Nicole Nitschke, Katja Weiß, Christel Seiz, Elena Affolter, Annette Jungbauer, Frederic Lammert, Anne Rotter, Nicole Ludwig, Sonja Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
title | Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
title_full | Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
title_fullStr | Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
title_full_unstemmed | Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
title_short | Plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
title_sort | plasma-derived small extracellular vesicles unleash the angiogenic potential in head and neck cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207688/ https://www.ncbi.nlm.nih.gov/pubmed/37226100 http://dx.doi.org/10.1186/s10020-023-00659-w |
work_keys_str_mv | AT tenglerluisa plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT schutzjulia plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT tiedtkemoritz plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT jablonskajadwiga plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT theodorakimarienicole plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT nitschkekatja plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT weißchristel plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT seizelena plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT affolterannette plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT jungbauerfrederic plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT lammertanne plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT rotternicole plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients AT ludwigsonja plasmaderivedsmallextracellularvesiclesunleashtheangiogenicpotentialinheadandneckcancerpatients |